Skip to main content
. 2012 Nov 26;10:254. doi: 10.1186/1477-7819-10-254

Table 2.

Clinicopathological characteristics

Variable PDAC
uMAC
SRC
P-value
n= 1002 n= 54 n= 320  
Age, years (mean ± SD)
54.6 ± 12.8
57.3 ± 12.1
52.4 ± 12.0
0.003
Gender, n (%)
 
 
 
 
 Male
605 (60.4)
35 (64.8)
187 (58.4)
0.637
 Female
397 (39.6)
19 (35.2)
133 (41.6)
 
Multiplicity, n (%)
 
 
 
 
 Single
982 (98.0)
53 (98.1)
316 (98.8)
0.612
 Multiple
20 (2.0)
1 (1.9)
4 (1.3)
 
Tumor location, n (%)
 
 
 
 
 Upper
108 (10.8)
4 (7.4)
22 (6.9)
0.184
 Middle
392 (39.1)
17 (31.5)
141 (44.1)
 
 Lower
452 (45.1)
31 (57.4)
139 (43.4)
 
 Whole
50 (5.0)
2 (3.7 %)
18 (5.6)
 
Tumor size, cm (mean ± SD)
5.7 ± 3.7
7.1 ± 3.8
4.8 ± 3.2
<0.001
Lauren, n (%)
 
 
 
 
 Intestinal type
0 (0)
0 (0)
0 (0)
<0.001
 Diffuse type
782 (78.0)
37 (68.5)
290 (90.6)
 
Mixed type
220 (22.0)
17 (31.5)
30 (9.4)
 
Lymphatic invasion, n (%)
 
 
 
 
 Present
607 (60.6)
42 (77.8)
120 (37.5)
<0.001
 Absent
395 (39.4)
12 (22.2)
200 (62.5)
 
Vascular invasion, n (%)
 
 
 
 
 Present
105 (10.5)
12 (22.2)
27 (8.4)
0.009
 Absent
897 (89.5)
42 (77.8)
293 (91.6)
 
Perineural invasion, n (%)
 
 
 
 
 Present
490 (48.9)
29 (53.7)
108 (33.8)
<0.001
 Absent
512 (51.1)
25 (46.3)
212 (66.3)
 
Depth of invasion, n (%)
 
 
 
 
 T1
248 (24.8)
3 (5.6)
164 (51.3)
<0.001
 T2
152 (15.2)
4 (7.4)
32 (10.0)
 
 T3
242 (24.2)
13 (24.1)
40 (12.5)
 
 T4
360 (35.9)
34 (63.0)
84 (26.3)
 
Lymph node metastasis, n (%)
 
 
 
 
 N0
422 (42.1)
9 (16.7)
201 (62.8)
<0.001
 N1
134 (13.4)
11 (20.4)
25 (7.8)
 
 N2
131 (13.1)
10 (18.5)
27 (8.4)
 
 N3
315 (31.4)
24 (44.4)
67 (20.9)
 
Pathological stage, n (%)
 
 
 
 
 I
323 (32.2)
4 (7.4)
180 (56.3)
<0.001
 II
212 (21.2)
11 (20.4)
50 (15.6)
 
 III
354 (35.3)
30 (55.6)
64 (20.2)
 
 IV 113 (11.3) 9 (16.7) 26 (8.1)